Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001804220-25-000022
Filing Date
2025-04-29
Accepted
2025-04-29 06:51:48
Documents
72
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q regn-20250331.htm   iXBRL 10-Q 1722803
2 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) regn-ex_311x03312025x10q.htm EX-31.1 12002
3 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) regn-ex_312x03312025x10q.htm EX-31.2 12071
4 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C SECTION 1350 regn-ex_32x03312025.htm EX-32 6864
  Complete submission text file 0001804220-25-000022.txt   6932326

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20250331.xsd EX-101.SCH 39987
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT regn-20250331_cal.xml EX-101.CAL 63765
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT regn-20250331_def.xml EX-101.DEF 232938
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20250331_lab.xml EX-101.LAB 513910
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20250331_pre.xml EX-101.PRE 370478
75 EXTRACTED XBRL INSTANCE DOCUMENT regn-20250331_htm.xml XML 920698
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 25882571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)